Article
Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to…
medRxiv · 2022 · Steven Swendeman
Key facts
| Title | Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to combat endothelial dysfunction and thromboinflammation |
|---|---|
| First author | Steven Swendeman |
| Journal | medRxiv |
| Published | Feb 14, 2022 |
| DOI | 10.1101/2022.02.14.480375 |
| Devices mentioned | K021671 |
| Product codes mentioned | JIT, JJY, LBS, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1